Cytosorbents financials at a glance

+ Portfolio

The revenue of Cytosorbents is reported as 0.03635 billion Dollars in the fiscal year 2023. The earnings were -0.64 Dollars per share in 2023, which was 14.67 higher than 2022. And about -0.02181 billion Dollars are reported as free cash flow in the financials of Cytosorbents 2023. No dividends were paid to the shareholders of the Cytosorbents stock NasdaqCM:CTSO in the financial year 2023.

$36.35M

Revenue

$-0.64

Earnings Per Share

61.60%

Gross Margin %

$-18.54M

Free Cash Flow

Revenue

36.35

Earnings Per Share

-0.64

Gross Margin %

61.60

Free Cash Flow

-18.54

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Rev.	Revenue	N/A	$36.35M	$34.69M	$43.17M	$41.00M	$24.95M	$22.50M	$15.15M	$9.53M	$4.79M	$4.12M	$2.42M	$1.34M
GM %	Gross Margin %	61.60%	61.60%	59.77%	29.06%	73.05%	70.48%	66.72%	63.58%	58.50%	53.82%	48.24%	21.10%	76.22%
OM	Operating Margin	-76.01%	-83.28%	-90.87%	-0.94%	-25.29%	-76.05%	-69.25%	-64.96%	-,120.62%	-,194.17%	-,167.19%	-,194.55%	-,259.94%
EPS	Earnings Per Share	$-0.53	$-0.64	$-0.75	$-0.57	$-0.20	$-0.60	$-0.56	$-0.32	$-0.47	$-0.33	$-1.29	$-0.75	$-0.75
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	54.29M	43.66M	43.51M	43.26M	35.05M	31.86M	29.47M	25.52M	25.41M	24.64M	10.05M	8.6M
OCF	Operating Cash Flow	N/A	$-21.66M	$-28.23M	$0.00M	$-5.61M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$6.66M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-18.54M	$-34.32M	$0.00M	$-6.32M	$-18.28M	$-12.36M	$-7.45M	$-6.87M	$0.00M	$-6.81M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.49	$-0.51	$-0.80	$-0.42	$-0.19	$-0.57	$-0.40	$-0.29	$-0.29	$-0.39	$-0.46	$-0.39	$-0.46

Cytosorbents financials at a glance

Financials

Discover